| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03721e344a72026d125291e6c56c1be6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-26 |
| filingDate |
1990-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_285adc511ff3ccafa90ef326e23e6914
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83c8bb59b95a8f2a35ea140bed707e63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e625905c4d9ecddd7004021bd6f1bd8b |
| publicationDate |
1992-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0479786-A1 |
| titleOfInvention |
Treatment for cocaine addiction |
| abstract |
The toxic effects of cocaine can be blocked by chronic administration of carbamazepine in an amount sufficient to achieve a blood concentration of 4 to 12 mug / ml. In addition, the administration of carbamazepine blocks the strengthening effects of cocaine, thereby decreasing the likelihood of developing cocaine addiction. |
| priorityDate |
1989-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |